Common questions about Lexapro (FAQ)
Q: Is Lexapro the same as other SSRI medicines, and if not, how is it different?
A: Lexapro is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). Official documents describe the active ingredient, escitalopram, as chemically distinct because it is the single, purified S-enantiomer of a related compound. This specific chemical structure is what sets it apart from some other SSRI medications.
Q: How long does it usually take to feel the effects of Lexapro?
A: Studies and official information indicate that the effects of Lexapro are not immediate. Clinical trials typically track changes in symptoms over an observation period of 8 to 12 weeks. Regulatory documents indicate monitoring for a potential response is part of the clinical process and often involves several weeks.
Q: Can Lexapro cause changes in appetite or weight?
A: Regulatory safety information indicates that changes in appetite and weight are possible documented effects. Official adverse reaction lists include both decreased appetite or loss of appetite, as well as increased appetite and weight gain.
Q: Is it common for people to feel more anxious when first starting Lexapro?
A: Regulatory information notes that some patients may experience restlessness or anxiety as reported adverse events. This is especially true early in the course of treatment. Official documents state that monitoring for these changes is required during the initial period of treatment or after dose adjustments.
Q: Can Lexapro affect sleep patterns, such as causing insomnia or excessive sleepiness?
A: Yes, official adverse reaction documents list effects that can alter sleep. Both insomnia (trouble sleeping) and somnolence (unusual drowsiness or sleepiness) are cited as common documented effects of the medication.
Q: What are the most commonly reported side effects according to official prescribing information?
A: According to the official prescribing information, the most frequently reported effects (occurring in 10% or more of patients in clinical data) are nausea and headache. These are listed as Very Common adverse reactions.
Q: Is it true that Lexapro may affect sexual function?
A: Official regulatory safety information confirms that sexual disturbances are documented effects. These commonly include decreased sexual drive (libido), ejaculation disorder (in males), and difficulties achieving orgasm (in females).
Q: Can Lexapro cause changes in blood pressure or heart rate?
A: Official labeling warns that the active ingredient in Lexapro may cause changes in heart rhythm, specifically by prolonging the QT interval. The labeling advises caution regarding use in patients with pre-existing heart conditions. Other serious effects mentioned include fast or irregular heartbeats.
Q: What is the typical time frame for side effects to start or stop after beginning Lexapro?
A: Official patient documents state that many side effects are mild and may disappear after a few days of starting treatment. If effects are persistent or become problematic, regulatory information encourages seeking clinical guidance.
Q: Are there any official warnings about taking Lexapro if I have glaucoma?
A: Regulatory information includes an explicit warning for patients with angle-closure glaucoma. This is because the drug may cause the pupil of the eye to dilate, which could potentially trigger an acute attack.
Q: Why is it important to tell your prescriber about all other medicines when starting Lexapro?
A: Full disclosure of all medicines is important because Lexapro can interact with many substances. Regulatory documents detail that co-administration with other medicines can lead to contraindicated combinations, increased risk of serious conditions like Serotonin Syndrome, or altered drug exposure due to enzyme effects.
Q: What does the term 'selective serotonin reuptake inhibitor' (SSRI) mean in simple terms?
A: An SSRI, or Selective Serotonin Reuptake Inhibitor, is a class of drug whose core mechanism is to temporarily block the neuronal reuptake of the neurotransmitter serotonin. This action enhances the presence of serotonin in the brain, helping to regulate chemical activity associated with mood and anxiety.
Q: Is it possible for Lexapro to affect my energy levels?
A: Regulatory adverse reaction lists include effects that relate to energy levels. These include somnolence (sleepiness) and fatigue, which are documented side effects that may be experienced by patients.
Q: Why are people often told to watch for behavioral changes when starting this medication?
A: Regulatory documents require close monitoring for certain changes in behavior, particularly during the initial months of treatment or following dose adjustments. This monitoring is required due to the potential for increased suicidal thoughts and behaviors and associated behaviors like agitation or irritability.
Q: How do doctors monitor the effectiveness of Lexapro?
A: Official labeling states that effectiveness is assessed clinically by monitoring for changes in symptoms, particularly during the initial phase of treatment. Clinical trials use specific rating scales to track improvement. Monitoring for worsening symptoms is also a key required part of the process.
Q: Is it required to have regular blood tests while taking Lexapro?
A: Official documents cite the risk of Hyponatremia (low sodium levels) as a serious adverse reaction, especially in older adults. This condition is monitored clinically, and testing of blood sodium levels may be utilized.
Q: Does the efficacy of Lexapro depend on the specific condition being treated?
A: Regulatory documents cite separate efficacy results and approved indications for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD). This suggests that its expected effect is tied to and evaluated based on the specific condition for which it is prescribed.
Q: Are there any official statements about Lexapro's potential interaction with herbal supplements like St. John's Wort?
A: Official regulatory documents explicitly state that combining Lexapro with other serotonergic agents, including St. John's Wort, can increase the risk of Serotonin Syndrome.
Q: What is the evidence regarding Lexapro and cognitive function?
A: Official labeling notes that the medication has been associated with effects on the Central Nervous System. This includes documented interference with both cognitive and motor performance.
Q: Can Lexapro affect my coordination or balance?
A: Official labeling lists adverse effects such as dizziness and sleepiness (somnolence). Serious risks like loss of coordination (as a symptom of Serotonin Syndrome or low sodium levels) are also documented effects that may affect balance and coordination.
Q: What information is available about the long-term use of Lexapro?
A: Regulatory documents discuss maintenance studies that followed adults with Major Depressive Disorder for periods up to 36 weeks to evaluate long-term response. While this data exists, official documents also note evidence gaps for periods extending far beyond the initial treatment and maintenance phases.
Q: Can Lexapro be used to treat things other than major depression and generalized anxiety disorder?
A: Regulatory documents list the drug’s officially approved uses as Major Depressive Disorder (MDD) in adults and adolescents, and Generalized Anxiety Disorder (GAD) in adults. The scope of official approval is limited to these indications.
Q: What is the general patient population Lexapro is intended to treat?
A: The official approved indications state the drug is approved for the treatment of Major Depressive Disorder and Generalized Anxiety Disorder. Eligibility for use is determined by age, concurrent medications, and pre-existing health conditions.
Q: Is Lexapro generally considered a short-term or a long-term treatment option?
A: Official regulatory documents indicate that Lexapro is intended as a treatment that extends beyond the acute period. They state that maintenance treatment and continued use for several months or longer is often required.
Q: Are there warnings about driving or operating machinery while on Lexapro?
A: Official labeling states that the drug may cause dizziness, fatigue, or visual disturbance, and advises against driving or operating machinery until the patient knows how the medication affects them.
Q: Has Lexapro been studied for use in treating conditions like obsessive-compulsive disorder (OCD)?
A: While the US FDA label lists MDD and GAD, some international regulatory information mentions Obsessive-Compulsive Disorder (OCD) as an indication for which the drug has been used.
Q: Is there a known 'ceiling' dose for Lexapro effectiveness?
A: Regulatory documents state the maximum recommended daily dose is 20 mg. Clinical trials for Major Depressive Disorder specifically noted that a 20 mg dose failed to demonstrate a greater benefit compared to the 10 mg dose, which relates to an effectiveness limit.
Q: Why is a slow reduction of the dose described when stopping Lexapro?
A: Regulatory documents recommend that the dose be gradually reduced (tapered) when stopping the medication. This is done to manage and reduce the potential for discontinuation symptoms, such as dizziness, agitation, anxiety, or abnormal dreams.
Q: What is the difference between brand-name Lexapro and its generic form?
A: Lexapro is the brand name of the medicine, and escitalopram is the generic (active) ingredient. Both the brand-name product and its generic equivalent contain the same active ingredient and are subject to the same regulatory standards.
Q: Is the liquid solution form of Lexapro used for specific patient groups?
A: The official label states that the oral solution (1 mg/ mL) is available. This form is often used to provide a flexible dosing option for patients who may have difficulty swallowing tablets.
